source
- STAT+: PhRMA taps Eric Cantor as new CEOEric Cantor, a former GOP House majority leader, is taking the helm of PhRMA at a challenging time for the industry.STAT · 22d ago↗ source
- UniQure tumbles with latest data for Huntington’s gene therapyAnalysts guessed that investors wanted to see stronger durability results at a four-year check-in of the key trial supporting a potential approval of "AMT-130."BioPharma Dive · 22d ago↗ source
- Merck pulls Recarbrio antibiotic from U.S. market, raising concerns over superbug resistanceMerck announced it has stopped supplying Recarbrio in the United States earlier this month. Recarbrio, a three‑drug combination injection approved seven years ago, is used for severe infections su…STAT · 23d ago